Meagan is a strategist and systems thinker who has spent her career helping founders, investors, executives, and clinicians navigate complexity across technology, operations, and emerging digital health and biotech. Her strength lies in seeing the full ecosystem: the biology, the business models, the data infrastructure, and the real-world constraints. Because longevity is inherently multidisciplinary, she helps integrate the pieces — biotech, biomarkers, neurotech, AI, metabolic health, nutrition, legal, insurance, and capital — into coherent, future-ready strategies.

Meagan works with longevity and healthspan teams who recognize that the future of longevity isn't about isolated breakthroughs — it's about strategic integration.